Cargando…

Dextroamphetamine-Amphetamine Augmentation in the Treatment of Treatment-Resistant Depression

There is much debate over a precise definition of treatment-resistant depression (TRD) as well as the method of staging this illness. Although there is some non-consensus on a definition for TRD, the most widely accepted definition of TRD is a failure to achieve clinical improvement of depressive sy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Small, Tyler M, Dhat, Sanket, Faruqui, Zeeshan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2022
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445411/ https://www.ncbi.nlm.nih.gov/pubmed/36106259 http://dx.doi.org/10.7759/cureus.27755

Ejemplares similares

Central serous chorioretinopathy associated with Adderall (dextroamphetamine-amphetamine) and topical steroid use
por: Alsberge, Joseph B., et al.
Publicado: (2022)

Dextroamphetamine Treatment for Children With Hypothalamic Obesity
por: van Schaik, Jiska, et al.
Publicado: (2021)

Dextroamphetamine Treatment in Children With Hypothalamic Obesity
por: van Schaik, Jiska, et al.
Publicado: (2022)

Interactions Between Opioids and Dextroamphetamine on Locomotor Activity: Influence of an Opioid's Relative Efficacy at the Mu Receptor
por: Smith, Mark A., et al.
Publicado: (2022)

Amphetamine-Dextroamphetamine-Induced Cardiomyopathy, an Emerging Cause of Heart Failure in Young Patient Populations: A Case Study Involving the Study Drug
por: Lewars, Jennaire T, et al.
Publicado: (2023)

Combination of Modafinil and d-amphetamine for the Treatment of Cocaine Dependence: A Preliminary Investigation
por: Schmitz, Joy M., et al.
Publicado: (2012)

Negative Impact of Amphetamine-Type Stimulant Use on Opioid Agonist Treatment Retention in Ontario, Canada
por: Morin, Kristen A., et al.
Publicado: (2021)

Case report: Prazosin augmentation for treating comorbid treatment-resistant depression and chronic post-traumatic stress disorder
por: Guo, Ping, et al.
Publicado: (2022)

Functional Genomic Analysis of Amphetamine Sensitivity in Drosophila
por: Karam, Caline S., et al.
Publicado: (2022)

Antipsychotics for Amphetamine Psychosis. A Systematic Review
por: Fluyau, Dimy, et al.
Publicado: (2019)

Effects of Lisdexamfetamine, a Prodrug of D-Amphetamine, on Locomotion, Spatial Cognitive Processing and Neurochemical Profiles in Rats: A Comparison With Immediate-Release Amphetamine
por: Jian-min, Chen, et al.
Publicado: (2022)

Editorial: Alternative treatments to classical antidepressants in treatment-resistant depression
por: Mikellides, Georgios, et al.
Publicado: (2023)

Hippocampal subfield volumes in treatment resistant depression and serial ketamine treatment
por: Zavaliangos-Petropulu, Artemis, et al.
Publicado: (2023)

Efficacy of Individualized Homeopathy in Treatment-Resistant Depression
por: Zepeda-Quiroz, Noheli, et al.
Publicado: (2021)

Development and Validation of the Amphetamine-Type Stimulants Motive Questionnaire in a Clinical Population
por: Thurn, Daniela, et al.
Publicado: (2017)

Psychosocial Interventions for Amphetamine Type Stimulant Use Disorder: An Overview of Systematic Reviews
por: Tran, Mai Thi Ngoc, et al.
Publicado: (2021)

Exploring the effectiveness of dextroamphetamine for the treatment of stimulant use disorder: a qualitative study with patients receiving injectable opioid agonist treatment
por: Palis, Heather, et al.
Publicado: (2021)

Treatment-Resistant Depression in Portugal: Perspective From Psychiatry Experts
por: Bessa, João M., et al.
Publicado: (2022)

The Incidental Resolution of Severe Alcohol Use Disorder during Esketamine Treatment of Major Depressive Disorder: A Case Report
por: Faruqui, Zeeshan, et al.
Publicado: (2022)

Use of sustained release dextroamphetamine for the treatment of stimulant use disorder in the setting of injectable opioid agonist treatment in Canada: a case report
por: Palis, Heather, et al.
Publicado: (2021)

Prevalence and Correlates of Active Amphetamine-Type Stimulant Use Among Female Sex Workers in Malaysia
por: Pedersen, Courtney J., et al.
Publicado: (2022)

Economic evaluation of interventions for treatment-resistant depression: A systematic review
por: Hannah, Laura A., et al.
Publicado: (2023)

Repetitive Transcranial Magnetic Stimulation in Youth With Treatment Resistant Major Depression
por: MacMaster, Frank P., et al.
Publicado: (2019)

Cortisol Modulation by Ayahuasca in Patients With Treatment Resistant Depression and Healthy Controls
por: Galvão, Ana C. de Menezes, et al.
Publicado: (2018)

Psychoactive drugs and false memory: comparison of dextroamphetamine and delta-9-tetrahydrocannabinol on false recognition
por: Ballard, Michael E., et al.
Publicado: (2011)

Quest for Biomarkers of Treatment-Resistant Depression: Shifting the Paradigm Toward Risk
por: Smith, Donald F.
Publicado: (2013)

Antianhedonic Effect of Repeated Ketamine Infusions in Patients With Treatment Resistant Depression
por: Wilkowska, Alina, et al.
Publicado: (2021)

Biological correlates of treatment resistant depression: a review of peripheral biomarkers
por: Mancuso, Emiliana, et al.
Publicado: (2023)

Treatment-Resistant Depression in America Latina study: one-year follow-up of treatment resistant depression patients under standard of care reveals insights on quality of life, disability, work impairment, and depressive symptoms
por: Recco, Kelen, et al.
Publicado: (2023)

Deep Brain Stimulation Neuromodulation for the Treatment of Mood Disorders: Obsessive Compulsive Disorder and Treatment Resistant Depression
por: Marquez-Franco, Rene, et al.
Publicado: (2022)

Decreased Resting-State Connectivity between Neurocognitive Networks in Treatment Resistant Depression
por: de Kwaasteniet, Bart P., et al.
Publicado: (2015)

Associations of Suicide Risk and Community Integration Among Patients With Treatment-Resistant Depression
por: Huong, Pham Thi Thu, et al.
Publicado: (2022)

Growth Factor Proteins and Treatment-Resistant Depression: A Place on the Path to Precision
por: Pisoni, Alice, et al.
Publicado: (2018)

Neural and Behavioral Correlates of Clinical Improvement to Ketamine in Adolescents With Treatment Resistant Depression
por: Thai, Michelle, et al.
Publicado: (2020)

Case Report: Lateral Habenula Deep Brain Stimulation for Treatment-Resistant Depression
por: Wang, Zhiyan, et al.
Publicado: (2021)

Altered Brain Function in Treatment-Resistant and Non-treatment-resistant Depression Patients: A Resting-State Functional Magnetic Resonance Imaging Study
por: Sun, Jifei, et al.
Publicado: (2022)

Metabotropic glutamate type 5 receptor binding availability during dextroamphetamine sensitization in mice and humans
por: Smart, Kelly, et al.
Publicado: (2021)

Clinical Guidelines of the Egyptian Psychiatric Association for the Management of Treatment-Resistant Unipolar Depression in Egypt
por: Abdel-Wahab, Momtaz, et al.
Publicado: (2022)

Treatment-Resistant Major Depression: Rationale for NMDA Receptors as Targets and Nitrous Oxide as Therapy
por: Zorumski, Charles F., et al.
Publicado: (2015)

Efficacy and Safety of Intranasal Esketamine in Treatment-Resistant Depression in Adults: A Systematic Review
por: Sapkota, Alisha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_brbta2sv17jblupdhsg10vacee